The role of third-generation epithelial growth factor receptor inhibitors in non-small cell lung cancer.
作者信息
Sequist Lecia V
机构信息
Harvard Medical School, Boston, Massachusetts.
出版信息
Clin Adv Hematol Oncol. 2015 Mar;13(3):147-9.
PMID:26352419
Abstract
摘要
相似文献
1
The role of third-generation epithelial growth factor receptor inhibitors in non-small cell lung cancer.
Clin Adv Hematol Oncol. 2015 Mar;13(3):147-9.
2
Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives.
Future Oncol. 2017 Feb;13(3):201-204. doi: 10.2217/fon-2016-0325. Epub 2016 Sep 14.
3
First-line treatment for advanced nonsmall cell lung cancer harboring activating epidermal growth factor receptor mutation: epidermal growth factor receptor tyrosine kinase inhibitors or chemotherapy?
Curr Opin Oncol. 2011 Mar;23(2):131-2. doi: 10.1097/CCO.0b013e328341ee26.
4
Current and future targeted therapies for non-small-cell lung cancers with aberrant EGF receptors.
Future Oncol. 2015;11(5):865-78. doi: 10.2217/fon.14.312.
5
Relevance of epidermal growth factor receptor genomic gain in predicting clinical response to kinase inhibitors in non-small-cell lung cancer.
Clin Lung Cancer. 2005 Nov;7(3):163-5. doi: 10.1016/S1525-7304(11)70404-1.
6
Targeting the MET gene for the treatment of non-small-cell lung cancer.
Crit Rev Oncol Hematol. 2014 Feb;89(2):284-99. doi: 10.1016/j.critrevonc.2013.11.006. Epub 2013 Dec 1.
7
The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer.
Oncologist. 2005 Aug;10(7):467-70. doi: 10.1634/theoncologist.10-7-467.
8
Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.
Expert Opin Pharmacother. 2010 Oct;11(14):2363-89. doi: 10.1517/14656566.2010.498581.
9
Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.
J Clin Oncol. 2007 Feb 10;25(5):587-95. doi: 10.1200/JCO.2006.07.3585.
10
Epidermal Growth Factor Receptor-Mutant Lung Cancer: New Drugs, New Resistance Mechanisms, and Future Treatment Options.
Cancer J. 2015 Sep-Oct;21(5):371-7. doi: 10.1097/PPO.0000000000000147.
引用本文的文献
1
Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma.
Open Med (Wars). 2016 Mar 26;11(1):68-77. doi: 10.1515/med-2016-0014. eCollection 2016.
Zotero 插件